318 related articles for article (PubMed ID: 7529717)
21. Dynamics of anti-MSP3 and Pfs230 antibody responses and multiplicity of infection in asymptomatic children from southern Ghana.
Amoah LE; Acquah FK; Ayanful-Torgby R; Oppong A; Abankwa J; Obboh EK; Singh SK; Theisen M
Parasit Vectors; 2018 Jan; 11(1):13. PubMed ID: 29304870
[TBL] [Abstract][Full Text] [Related]
22. Plasmodium falciparum: analysis of the cytoadherence inhibition of the human monoclonal antibody 33G2 and of antibodies reactive with antigen Pf332.
Iqbal J; Perlmann P; Berzins K
Exp Parasitol; 1993 Aug; 77(1):79-87. PubMed ID: 8344409
[TBL] [Abstract][Full Text] [Related]
23. Transmission blocking immunity as observed in a feeder system and serological reactivity to Pfs 48/45 and Pfs230 in field sera.
Roeffen W; Lensen T; Mulder B; Teelen K; Sauerwein R; Eling W; Meuwissen JH; Beckers P
Mem Inst Oswaldo Cruz; 1994; 89 Suppl 2():13-5. PubMed ID: 7565122
[TBL] [Abstract][Full Text] [Related]
24. [Preparation and characterization of monoclonal antibodies against erythrocyte-binding antigen 175 of Plasmodium falciparum].
Hao WB; Hong YH; Sun XM; Ning Y; Zhang DM; Pan WQ; Li M
Di Yi Jun Yi Da Xue Xue Bao; 2005 Sep; 25(9):1169-71. PubMed ID: 16174591
[TBL] [Abstract][Full Text] [Related]
25. Transmission-reducing immunity is inversely related to age in Plasmodium falciparum gametocyte carriers.
Drakeley CJ; Bousema JT; Akim NI; Teelen K; Roeffen W; Lensen AH; Bolmer M; Eling W; Sauerwein RW
Parasite Immunol; 2006 May; 28(5):185-90. PubMed ID: 16629703
[TBL] [Abstract][Full Text] [Related]
26. Immunity to sexual stages of human malaria parasites: immune modulation during natural infections, antigenic determinants, and the induction of transmission-blocking immunity.
Targett G
Scand J Infect Dis Suppl; 1990; 76():79-88. PubMed ID: 1714627
[TBL] [Abstract][Full Text] [Related]
27. A protective merozoite protein of Plasmodium falciparum shares an epitope with surface antigens of Paramecium.
Sehgal A; Singh NJ; Chakraborty T; Sharma S
Parasite Immunol; 2004 May; 26(5):219-27. PubMed ID: 15491471
[TBL] [Abstract][Full Text] [Related]
28. Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro.
Locher CP; Tam LQ; Chang SP; McBride JS; Siddiqui WA
Exp Parasitol; 1996 Oct; 84(1):74-83. PubMed ID: 8888734
[TBL] [Abstract][Full Text] [Related]
29. Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230.
Healer J; McGuinness D; Hopcroft P; Haley S; Carter R; Riley E
Infect Immun; 1997 Aug; 65(8):3017-23. PubMed ID: 9234748
[TBL] [Abstract][Full Text] [Related]
30. The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania.
Bousema T; Roeffen W; Meijerink H; Mwerinde H; Mwakalinga S; van Gemert GJ; van de Vegte-Bolmer M; Mosha F; Targett G; Riley EM; Sauerwein R; Drakeley C
PLoS One; 2010 Nov; 5(11):e14114. PubMed ID: 21124765
[TBL] [Abstract][Full Text] [Related]
31. Reduction and enhancement of Plasmodium falciparum transmission by endemic human sera.
van der Kolk M; de Vlas SJ; Sauerwein RW
Int J Parasitol; 2006 Sep; 36(10-11):1091-5. PubMed ID: 16790244
[TBL] [Abstract][Full Text] [Related]
32. Humoral immune responses to Plasmodium falciparum antigens in children and adults living in a hypoendemic area of Punjab (Pakistan).
Iqbal J; Rab A; Perlmann P; Berzins K
Am J Trop Med Hyg; 1994 Oct; 51(4):444-53. PubMed ID: 7943571
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of malaria transmission-blocking vaccine candidate, y230.CA14 following crosslinking in the presence of tetanus toxoid.
Vincent AA; Fanning S; Caira FC; Williamson KC
Parasite Immunol; 1999 Nov; 21(11):573-81. PubMed ID: 10583858
[TBL] [Abstract][Full Text] [Related]
34. ELISA units, IgG subclass ratio and avidity determined functional activity of mouse anti-Pfs230 antibodies judged by a standard membrane-feeding assay with Plasmodium falciparum.
Miura K; Deng B; Wu Y; Zhou L; Pham TP; Diouf A; Wu CK; Lee SM; Plieskatt JL; Morin MJ; Long CA
Vaccine; 2019 Apr; 37(15):2073-2078. PubMed ID: 30850239
[TBL] [Abstract][Full Text] [Related]
35. Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent.
Roeffen W; Geeraedts F; Eling W; Beckers P; Wizel B; Kumar N; Lensen T; Sauerwein R
Infect Immun; 1995 Feb; 63(2):467-71. PubMed ID: 7822011
[TBL] [Abstract][Full Text] [Related]
36. Antibody recognition of heterologous variant surface antigens after a single Plasmodium falciparum infection in previously naive adults.
Elliott SR; Payne PD; Duffy MF; Byrne TJ; Tham WH; Rogerson SJ; Brown GV; Eisen DP
Am J Trop Med Hyg; 2007 May; 76(5):860-4. PubMed ID: 17488905
[TBL] [Abstract][Full Text] [Related]
37. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
[TBL] [Abstract][Full Text] [Related]
38. Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25.
Quakyi IA; Miller LH; Good MF; Ahlers JD; Isaacs SN; Nunberg JH; Houghten RA; Keister DB; Coligan JE; Moss B
Pept Res; 1995; 8(6):335-44. PubMed ID: 8838417
[TBL] [Abstract][Full Text] [Related]
39. Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing.
Read D; Lensen AH; Begarnie S; Haley S; Raza A; Carter R
Parasite Immunol; 1994 Oct; 16(10):511-9. PubMed ID: 7532850
[TBL] [Abstract][Full Text] [Related]
40. Extending the range of Plasmodium falciparum transmission blocking antibodies.
Simons LM; Ferrer P; Gombakomba N; Underwood K; Herrera R; Narum DL; Canepa G; Acquah F; Amoah L; Duffy PE; Barillas-Mury C; Long C; Lee SM; Locke E; Miura K; Williamson KC
Vaccine; 2023 May; 41(21):3367-3379. PubMed ID: 37100721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
